Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Opthea ( (AU:OPT) ).
Opthea is a company operating in the pharmaceutical industry, focusing on developing critical medicines aimed at altering the course of devastating diseases. The company’s recent annual report highlights the inherent risks and bold strategies required in their industry to achieve these goals, emphasizing the importance of shareholder support in their mission.
The most recent analyst rating on (AU:OPT) stock is a Sell with a A$0.05 price target. To see the full list of analyst forecasts on Opthea stock, see the AU:OPT Stock Forecast page.
More about Opthea
YTD Price Performance: -25.93%
Technical Sentiment Signal: Sell
Current Market Cap: A$738.8M
For a thorough assessment of OPT stock, go to TipRanks’ Stock Analysis page.